Literature DB >> 11427274

Immune responses and protection in different strains of aged mice immunized intranasally with an adjuvant-combined influenza vaccine.

H Asanuma1, K Hirokawa, M Uchiyama, Y Suzuki, C Aizawa, T Kurata, T Sata, S Tamura.   

Abstract

Immune responses and protection against influenza virus infection were compared between young (2 months) and aged (18 months) BALB/c, C3H and C57BL/6 (B6) mice after intranasal vaccination. The mice were immunized with 2.5 microg protein of A/PR/8/34 (PR8) (H1N1) virus vaccine containing a cholera toxin adjuvant. In both the young and aged BALB/c mice, high levels of PR8-specific antibody-forming cell (AFC) responses were induced in the nasal-associated lymphoid tissue (NALT) 7 days after immunization. Nasal wash IgA and serum IgG antibody (Ab) responses to the PR8 haemagglutinin (HA) 4 weeks after immunization were slightly higher in the young mice than in the aged mice. The young mice showed complete protection against challenge infection, while the aged mice showed only a partial protection. In the C3H mice, NALT-AFC, and IgA and IgG Ab responses were higher in the young mice than those in the aged mice in parallel with the more efficient protection in the young mice than in the aged mice. Both the young and aged B6 mice showed no NALT-AFC responses, scarce IgA and IgG Ab responses and no protection. In the BALB/c mice, IgG1 and IgG2a levels were significantly lower in the aged mice. On the other hand, in the C3H mice, only IgG2a level was significantly lower in the aged mice. Similar results were obtained in terms of immune responses and protection between the young and aged mice of three different strains of mice after intra-nasal immunization with 0.1 microg of PR8 vaccine containing the adjuvant, two-times at 4-week intervals. In the B6 mice, the immune response was improved by immunization with a higher dose of the adjuvant-combined vaccine. These results suggest that local Ab responses, as well as systemic Ab responses, are downregulated in aged mice, although the degree of the downregulation of immune responses differs from strain to strain.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11427274     DOI: 10.1016/s0264-410x(01)00129-3

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  14 in total

Review 1.  Effect of vaccine administration modality on immunogenicity and efficacy.

Authors:  Lu Zhang; Wei Wang; Shixia Wang
Journal:  Expert Rev Vaccines       Date:  2015-08-27       Impact factor: 5.217

2.  Mucosal adjuvant activity of flagellin in aged mice.

Authors:  John T Bates; Anna N Honko; Aaron H Graff; Nancy D Kock; Steven B Mizel
Journal:  Mech Ageing Dev       Date:  2008-02-17       Impact factor: 5.432

3.  A novel combined adjuvant for nasal delivery elicits mucosal immunity to influenza in aging.

Authors:  Hideki Asanuma; Normaiza Binti Zamri; Shinichi Sekine; Yoshiko Fukuyama; Daisuke Tokuhara; Rebekah S Gilbert; Tatsuya Fukuiwa; Keiko Fujihashi; Tetsutaro Sata; Masato Tashiro; Kohtaro Fujihashi
Journal:  Vaccine       Date:  2011-11-17       Impact factor: 3.641

4.  Age and testosterone mediate influenza pathogenesis in male mice.

Authors:  Landon G Vom Steeg; Meghan S Vermillion; Olivia J Hall; Ornob Alam; Ross McFarland; Haolin Chen; Barry Zirkin; Sabra L Klein
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-11-04       Impact factor: 5.464

5.  Successful vaccination strategies that protect aged mice from lethal challenge from influenza virus and heterologous severe acute respiratory syndrome coronavirus.

Authors:  Timothy Sheahan; Alan Whitmore; Kristin Long; Martin Ferris; Barry Rockx; William Funkhouser; Eric Donaldson; Lisa Gralinski; Martha Collier; Mark Heise; Nancy Davis; Robert Johnston; Ralph S Baric
Journal:  J Virol       Date:  2010-10-27       Impact factor: 5.103

Review 6.  Influenza Pathogenesis: The Effect of Host Factors on Severity of Disease.

Authors:  Anshu P Gounder; Adrianus C M Boon
Journal:  J Immunol       Date:  2019-01-15       Impact factor: 5.422

7.  E47 retroviral rescue of intrinsic B-cell defects in senescent mice.

Authors:  Ana M Landin; Daniela Frasca; Patrick Harrison; Martina Scallan; Richard L Riley; Bonnie B Blomberg
Journal:  Aging Cell       Date:  2011-02-25       Impact factor: 9.304

8.  Expression quantitative trait Loci for extreme host response to influenza a in pre-collaborative cross mice.

Authors:  Daniel Bottomly; Martin T Ferris; Lauri D Aicher; Elizabeth Rosenzweig; Alan Whitmore; David L Aylor; Bart L Haagmans; Lisa E Gralinski; Birgit G Bradel-Tretheway; Janine T Bryan; David W Threadgill; Fernando Pardo-Manuel de Villena; Ralph S Baric; Michael G Katze; Mark Heise; Shannon K McWeeney
Journal:  G3 (Bethesda)       Date:  2012-02-01       Impact factor: 3.154

9.  Evaluation of serologic and antigenic relationships between middle eastern respiratory syndrome coronavirus and other coronaviruses to develop vaccine platforms for the rapid response to emerging coronaviruses.

Authors:  Sudhakar Agnihothram; Robin Gopal; Boyd L Yount; Eric F Donaldson; Vineet D Menachery; Rachel L Graham; Trevor D Scobey; Lisa E Gralinski; Mark R Denison; Maria Zambon; Ralph S Baric
Journal:  J Infect Dis       Date:  2013-11-18       Impact factor: 5.226

10.  Modeling host genetic regulation of influenza pathogenesis in the collaborative cross.

Authors:  Martin T Ferris; David L Aylor; Daniel Bottomly; Alan C Whitmore; Lauri D Aicher; Timothy A Bell; Birgit Bradel-Tretheway; Janine T Bryan; Ryan J Buus; Lisa E Gralinski; Bart L Haagmans; Leonard McMillan; Darla R Miller; Elizabeth Rosenzweig; William Valdar; Jeremy Wang; Gary A Churchill; David W Threadgill; Shannon K McWeeney; Michael G Katze; Fernando Pardo-Manuel de Villena; Ralph S Baric; Mark T Heise
Journal:  PLoS Pathog       Date:  2013-02-28       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.